Regulation Of Insulin Secretion Pathway Bioinformatics
Insulin is a peptide hormone that is responsible for helping with the regulation of carbohydrate and fat metabolism, as it causes the cells of various tissues to absorb glucose in various forms from the bloodstream. Insulin is produced in the beta cells of the islets of Langerhans located in the pancreas, and is ready to be released into the body once it is cleaved from its signal peptide. Once glucose enters the body, it migrates to the pancreas an enters the beta cell, which leads to membrane depolarization and opens the calcium channels, allowing calcium to flow into the cell. The increase of calcium inside the cell initiates the secretion of insulin through secretory vesicles that fuse with the cell membrane, and insulin enters the bloodstream and begins its job of regulating blood and cell glucose levels. There are factors other than glucose levels that can regulate insulin secretion, and they include KATP channels, cAMPS, beta cell mitochondria, and leucine. ATP is necessary for insulin secretion, and many of these factors control ATP levels, in turn helping to regulate the secretion of insulin into the bloodstream. Deficiencies in insulin or resistance to the protein can lead to diseases including diabetes mellitus and polycystic ovary syndrome.
Regulation Of Insulin Secretion Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Regulation Of Insulin Secretion below!
For more information on how to use Laverne, please read the How to Guide.
We have 1080 products for the study of the Regulation Of Insulin Secretion Pathway that can be applied to Western Blot, Chromatin Immunoprecipitation, Immunocytochemistry/Immunofluorescence, Flow Cytometry, Immunohistochemistry from our catalog of antibodies and ELISA kits.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.